InterShunt Technologies has filed a notice of an exempt offering of securities to raise $20,416,894.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, InterShunt Technologies is raising up to $20,416,894.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Harlee Sorkin played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About InterShunt Technologies
Heart Failure is one of the most debilitating medical issues we face. It is the leading cause of hospitalization and the single largest medicare expense. Ultimately, more than 1-in-9 people die from the condition. At InterShunt Technologies, Inc. we believe that left atrial decompression holds the key to reducing symptoms for those who suffer. We believe we can do this using a simple catheter procedure. Most important, we believe we can do this without the use of an implant.
To learn more about InterShunt Technologies, visit http://intershunt.com/
InterShunt Technologies Linkedin Page: https://www.linkedin.com/company/intershunt/
Contact:
Harlee Sorkin, Chief Executive Officer
314-974-4260
https://www.linkedin.com/in/harleesorkin/
SOURCE: http://www.intelligence360.io
Copyright (c) 2024 SI360 Inc. All rights reserved.